Form 4: Quaker Chemical CFO Reports Equity Vesting and New Grant

Quaker Chemical's EVP and CFO, Thomas Coler, reported the vesting and settlement of restricted stock units and dividend equivalent rights, alongside a new RSU grant and shares surrendered for tax obligations.

Summary

• Thomas Coler, Executive Vice President and Chief Financial Officer of Quaker Chemical Corp (KWR), reported multiple equity transactions on March 15, 2026.
• Mr. Coler acquired 666 shares of common stock through the conversion of Restricted Stock Units (RSUs) from a grant made on June 15, 2024.
• An additional 882 shares of common stock were acquired from the conversion of RSUs granted on March 15, 2025.
• 30 shares of common stock were acquired from the settlement of Dividend Equivalent Rights (DERs) associated with the 2024 and 2025 RSU grants.
• Mr. Coler disposed of 541 shares of common stock at a price of $118.45 per share to satisfy tax withholding obligations upon the partial vesting of certain restricted stock units.
• A new grant of 2,870 time-based Restricted Stock Units (RSUs) was awarded under the Company's Long-Term Performance Incentive Plan, which will vest in three annual installments beginning on March 15, 2027.
• Following these transactions, Mr. Coler beneficially owns 1,478 shares of common stock directly.
• He also beneficially owns 667 and 1,764 Restricted Stock Units from previous grants, and 2,870 Restricted Stock Units from the new grant.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as slightly positive, reflecting routine executive compensation and retention. The new RSU grant indicates continued commitment and alignment of the CFO's interests with the company's long-term performance.

Positives

• The vesting of previously granted Restricted Stock Units and Dividend Equivalent Rights indicates the successful achievement of past compensation milestones.
• A new grant of 2,870 time-based RSUs aligns the EVP, CFO's long-term interests with shareholder value creation and serves as a retention incentive.

Negatives

• 541 shares of common stock were surrendered to cover tax withholding obligations, which is a standard practice but reduces direct share ownership.

Future Outlook

The EVP, CFO has future equity vesting events scheduled, with the newly granted 2,870 Restricted Stock Units vesting in three annual installments beginning on March 15, 2027. This indicates continued long-term incentive alignment.

Industry Context

StockSavvy.ai notes that these transactions represent routine executive compensation activities, common across publicly traded companies. The granting and vesting of Restricted Stock Units and Dividend Equivalent Rights are standard mechanisms for aligning executive incentives with shareholder interests and for executive retention within the chemicals industry.

Stakeholder Impact

• Shareholders: The transactions reflect ongoing executive compensation, which is a standard cost of doing business. The new RSU grant aligns executive incentives with long-term shareholder value.
• Employees: No direct impact on general employees, but it highlights the company's executive compensation structure.

Next Steps

• Future vesting of remaining Restricted Stock Units from the June 15, 2024, and March 15, 2025 grants.
• Future vesting of the newly granted 2,870 Restricted Stock Units, commencing on March 15, 2027.

Key Dates

Keywords

KWR, Quaker Chemical, Form 4, Insider Transaction, Restricted Stock Units, RSU, Dividend Equivalent Rights, DER, Executive Compensation, Thomas Coler, Equity Grant, Vesting